Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Deciphera shares skyrocket as cancer drug improves progression-free survival

Deciphera Pharmaceuticals Inc.’s shares more than doubled after the drugmaker said a late-stage study met the main goal of helping stomach cancer patients live longer without their disease worsening.

Read More »

Lilly combo therapy succeeds in lung cancer study

Eli Lilly and Co.’s combination cancer treatment met the main goal of a late-stage clinical trial in testing on patients with a form of lung cancer, the drugmaker announced.

Read More »

Cancer deaths to rise to 9.6 million in 2018

Cancer will claim the lives of 9.6 million people in 2018, accounting for one in eight of all deaths among men and one in 11 among women, the WHO’s cancer research agency said.

Read More »

FDA to review Samsung Bioepis’ Herceptin copy

South Korea’s Samsung Bioepis said the U.S. FDA accepted for review its copy of Roche’s blockbuster breast cancer drug Herceptin for potential approval.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom